• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胸苷磷酸化酶受到5'-O-三苯甲基肌苷(KIN59)及相关化合物的非竞争性抑制。

Thymidine phosphorylase is noncompetitively inhibited by 5'-O-trityl-inosine (KIN59) and related compounds.

作者信息

Liekens S, Balzarini J, Hernández A I, De Clercq E, Priego E M, Camarasa M J, Pérez-Pérez M J

机构信息

Rega Institute for Medical Research, KU Leuven, Leuven, Belgium.

出版信息

Nucleosides Nucleotides Nucleic Acids. 2006;25(9-11):975-80. doi: 10.1080/15257770600888925.

DOI:10.1080/15257770600888925
PMID:17065049
Abstract

We found that 5'-O-trityl-inosine (KIN59) inhibits recombinant bacterial (E. coli) and human thymidine phosphorylase (TPase) with an IC50 of 44 microM and 67 microM, respectively. In contrast to previously described TPase inhibitors, KIN59 does not compete with thymidine (dThd) at the pyrimidine nucleoside-binding site or with inorganic phosphate (Pi) at the phosphate-binding site of the enzyme. These findings are strongly suggestive for the presence of an allosteric binding site at the enzyme. TPase is identical to the angiogenic protein platelet-derived endothelial cell growth factor (PD-ECGF). As such, PD-ECGF stimulates angiogenesis in the chick chorioallantoic membrane (CAM) assay. This angiogenic response was completely inhibited by KIN59. Inosine did not inhibit the enzyme or the angiogenic effect of TPase, confirming that the 5'-O-trityl group in KIN59 is essential for the observed effect. Our observations indicate that allosteric sites in TPase may regulate its biological activity.

摘要

我们发现5'-O-三苯甲基肌苷(KIN59)对重组细菌(大肠杆菌)和人胸苷磷酸化酶(TPase)具有抑制作用,其IC50分别为44微摩尔和67微摩尔。与先前描述的TPase抑制剂不同,KIN59不在嘧啶核苷结合位点与胸苷(dThd)竞争,也不在该酶的磷酸结合位点与无机磷酸(Pi)竞争。这些发现强烈提示该酶存在变构结合位点。TPase与血管生成蛋白血小板衍生的内皮细胞生长因子(PD-ECGF)相同。因此,PD-ECGF在鸡胚绒毛尿囊膜(CAM)试验中刺激血管生成。这种血管生成反应被KIN59完全抑制。肌苷不抑制该酶或TPase的血管生成作用,证实KIN59中的5'-O-三苯甲基基团对观察到的效应至关重要。我们的观察结果表明,TPase中的变构位点可能调节其生物学活性。

相似文献

1
Thymidine phosphorylase is noncompetitively inhibited by 5'-O-trityl-inosine (KIN59) and related compounds.胸苷磷酸化酶受到5'-O-三苯甲基肌苷(KIN59)及相关化合物的非竞争性抑制。
Nucleosides Nucleotides Nucleic Acids. 2006;25(9-11):975-80. doi: 10.1080/15257770600888925.
2
The nucleoside derivative 5'-O-trityl-inosine (KIN59) suppresses thymidine phosphorylase-triggered angiogenesis via a noncompetitive mechanism of action.核苷衍生物5'-O-三苯甲基肌苷(KIN59)通过非竞争性作用机制抑制胸苷磷酸化酶引发的血管生成。
J Biol Chem. 2004 Jul 9;279(28):29598-605. doi: 10.1074/jbc.M402602200. Epub 2004 May 3.
3
The thymidine phosphorylase inhibitor 5'-O-tritylinosine (KIN59) is an antiangiogenic multitarget fibroblast growth factor-2 antagonist.胸苷磷酸化酶抑制剂 5'-O-三苯甲基肌苷(KIN59)是一种抗血管生成的多靶点成纤维细胞生长因子-2 拮抗剂。
Mol Cancer Ther. 2012 Apr;11(4):817-29. doi: 10.1158/1535-7163.MCT-11-0738. Epub 2012 Feb 1.
4
5'-O-tritylated nucleoside derivatives: inhibition of thymidine phosphorylase and angiogenesis.5'-O-三苯甲基化核苷衍生物:对胸苷磷酸化酶和血管生成的抑制作用
Mol Pharmacol. 2006 Aug;70(2):501-9. doi: 10.1124/mol.105.021188. Epub 2006 May 4.
5
5'-O-tritylinosine and analogues as allosteric inhibitors of human thymidine phosphorylase.5'-O-三苯甲基肌苷及其类似物作为人胸苷磷酸化酶的变构抑制剂
J Med Chem. 2006 Sep 7;49(18):5562-70. doi: 10.1021/jm0605379.
6
Identification of aspartic acid-203 in human thymidine phosphorylase as an important residue for both catalysis and non-competitive inhibition by the small molecule "crystallization chaperone" 5'-O-tritylinosine (KIN59).鉴定人胸苷磷酸化酶中的天冬氨酸-203是小分子“结晶伴侣”5'-O-三苯甲基肌苷(KIN59)催化和非竞争性抑制的重要残基。
Biochem Pharmacol. 2009 Aug 1;78(3):231-40. doi: 10.1016/j.bcp.2009.04.011. Epub 2009 Apr 21.
7
[Influence of the thymidine phosphorylase (platelet-derived endothelial cell growth factor) on tumor angiogenesis. Catalytic activity of enzyme inhibitors].[胸苷磷酸化酶(血小板衍生内皮细胞生长因子)对肿瘤血管生成的影响。酶抑制剂的催化活性]
Postepy Biochem. 2010;56(1):61-6.
8
7-Deazaxanthine, a novel prototype inhibitor of thymidine phosphorylase.7-脱氮黄嘌呤,一种新型的胸苷磷酸化酶原型抑制剂。
FEBS Lett. 1998 Oct 30;438(1-2):91-5. doi: 10.1016/s0014-5793(98)01271-x.
9
Kinetic analysis of novel multisubstrate analogue inhibitors of thymidine phosphorylase.胸苷磷酸化酶新型多底物类似物抑制剂的动力学分析
FEBS Lett. 2000 Oct 20;483(2-3):181-5. doi: 10.1016/s0014-5793(00)02101-3.
10
Thymidine phosphorylase inhibitors: recent developments and potential therapeutic applications.
Mini Rev Med Chem. 2005 Dec;5(12):1113-23. doi: 10.2174/138955705774933301.

引用本文的文献

1
Targeting Thymidine Phosphorylase With Tipiracil Hydrochloride Attenuates Thrombosis Without Increasing Risk of Bleeding in Mice.盐酸替匹嘧啶抑制胸苷磷酸化酶可减轻小鼠血栓形成而不增加出血风险。
Arterioscler Thromb Vasc Biol. 2021 Feb;41(2):668-682. doi: 10.1161/ATVBAHA.120.315109. Epub 2020 Dec 10.
2
Natural compounds as angiogenic enzyme thymidine phosphorylase inhibitors: In vitro biochemical inhibition, mechanistic, and in silico modeling studies.天然化合物作为血管生成酶胸苷磷酸化酶抑制剂的研究:体外生化抑制、机制和计算模拟研究。
PLoS One. 2019 Nov 19;14(11):e0225056. doi: 10.1371/journal.pone.0225056. eCollection 2019.
3
Synthesis of new isoquinoline-base-oxadiazole derivatives as potent inhibitors of thymidine phosphorylase and molecular docking study.
合成新型异喹啉基-噁二唑衍生物作为胸苷磷酸化酶的有效抑制剂及分子对接研究。
Sci Rep. 2019 Nov 5;9(1):16015. doi: 10.1038/s41598-019-52100-0.
4
Synthesis of Thymidine Phosphorylase Inhibitor Based on Quinoxaline Derivatives and Their Molecular Docking Study.基于喹喔啉衍生物的胸苷磷酸化酶抑制剂的合成及其分子对接研究。
Molecules. 2019 Mar 13;24(6):1002. doi: 10.3390/molecules24061002.
5
Thymidine Phosphorylase in Cancer; Enemy or Friend?癌症中的胸苷磷酸化酶:敌还是友?
Cancer Microenviron. 2016 Apr;9(1):33-43. doi: 10.1007/s12307-015-0173-y. Epub 2015 Aug 23.